IRVINE, Calif., Oct. 06, 2023 — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate in the Jefferies Biotech CNS/Neuro Summit. Jefferies Biotech CNS/Neuro SummitDate: Wednesday, October 11, 2023 Location:… Continue reading Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
